A detailed history of Macroview Investment Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Macroview Investment Management LLC holds 126 shares of BMRN stock, worth $7,990. This represents 0.01% of its overall portfolio holdings.

Number of Shares
126
Holding current value
$7,990
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$69.02 - $93.84 $8,696 - $11,823
126 New
126 $8,000
Q3 2023

Oct 26, 2023

BUY
$85.07 - $94.48 $1,020 - $1,133
12 New
12 $1,000
Q4 2019

Feb 05, 2020

SELL
$64.27 - $86.37 $3,084 - $4,145
-48 Closed
0 $0
Q3 2019

Nov 04, 2019

BUY
$67.4 - $85.11 $3,235 - $4,085
48 New
48 $3,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.